NVAX
NVAX
NASDAQ · Biotechnology

Novavax Inc

$9.53
-0.55 (-5.46%)
As of Nov 7, 1:51 AM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 2 13%
Sell 3 20%
Price Target
Analyst Price Target +203.0% upside
Low Target $20.35
Average Target $28.88
High Target $29.25
Current Price $9.53
Current
$9.53
Target
$28.88
$20.35 $28.88 avg $29.25
Scenario Analysis
Bear Case
$20.35
113.5%
Low target
Base Case
$28.88
+203.0%
Avg target
Bull Case
$29.25
+206.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$13.39
-28.8% from high
52-Week Low
$6.20
+53.7% from low
Target vs 52W High
$28.88
+115.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%